MedPath
NMPA Approval

Canagliflozin Tablets

国药准字H20233014

January 9, 2023

Drug Information

卡格列净片

片剂

0.1g(按C₂₄H₂₅FO₅S计)

化学药品

January 9, 2023

Company Information

Applicant Company

连云港经济技术开发区长江路29号

Manufacturing Company

连云港经济技术开发区长江路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡格列净片 - NMPA 批准文号 | MedPath